Journal article icon

Journal article

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients

Abstract:

Objective: To assess the safety and efficacy of the Genous™ endothelial progenitor cell (EPC) capturing stent in conjunction with HmG-CoA-reductase inhibitors (statins) to stimulate EPC recruitment, in the treatment of patients with de novo coronary artery lesions. Methods and results: The HEALING IIB study was a multi-center, prospective trial, including 100 patients. The primary efficacy endpoint was late luminal loss by QCA at 6-month follow-up (FU). Although statin therapy increased relat...

Expand abstract

Actions


Access Document


Authors


den Dekker, WK More by this author
Houtgraaf, JH More by this author
de Winter, RJ More by this author
Expand authors...
Journal:
Atherosclerosis
Volume:
219
Issue:
1
Pages:
245-252
Publication date:
2011-11-05
DOI:
EISSN:
1879-1484
ISSN:
0021-9150
URN:
uuid:955c65c3-8614-402b-8de8-1a0d2fea7d95
Source identifiers:
206196
Local pid:
pubs:206196

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP